Abstract:Parkinson's disease (PD) is a complex and multifaceted neurodegenerative disorder that results from multiple environmental factors and multicellular interactions. Although several PD neuropathologies have been identified and described, the thorough understanding of PD pathophysiology and research has been largely limited by the absence of reliablein vitromodels that truly recapitulate PD microenvironments. Here, we propose a neuroimmune co-culture system that models PD neuropathologies by combining relevant multicellular interactions with environments that mimic the brain. This system is composed of: (i) 3D bioprinted cultures of mature human dopaminergic (DA) neurons grown on extracellular matrix (ECM)-derived scaffolds doped with electroconductive nanostructures, and (ii) a direct co-culture of human astrocytes and differentiated monocytes that models neuroinflammatory responses. When co-cultured in a transwell format, these two compartments recreate relevant multicellular environments that model PD pathologies after exposure to the neurotoxin A53Tα-synuclein. With immunofluorescent staining and gene expression analyses, we show that functional and mature DA 3D networks are generated within our ECM-derived scaffolds with superior performance to standard 2D cultures. Moreover, by analyzing cytokine secretion, cell surface markers, and gene expression, we define a human monocyte differentiation scheme that allows the appearance of both monocyte-derived macrophages and dendritic cell phenotypes, as well as their optimal co-culture ratios with human astrocytes to recreate synergistic neuroinflammatory responses. We show that the combined response of both compartments to A53Tα-synuclein stimulates the formation of intracellularα-synuclein aggregates, induces progressive mitochondrial dysfunction and reactive oxygen species production, downregulates the expression of synaptic, DA, and mitophagy-related genes, and promotes the initiation of apoptotic processes within the DA networks. Most importantly, these intracellular pathologies were comparable or superior to those generated with a rotenone-stimulated 2D control that represents the current standard forin vitroPD models and showed increased resilience towards these neurotoxic insults, allowing the study of disease progression over longer time periods than current models. Taken together, these results position the proposed model as a superior alternative to current 2D models for generating PD-related pathologiesin vitro.

Engineering Three-Dimensional Microenvironments Towards in Vitro Disease Models of the Central Nervous System

Bioprinting Neural Systems to Model Central Nervous System Diseases

Recent progresses in novel in vitro models of primary neurons: A biomaterial perspective

The Evolution of Technology‐Driven In Vitro Models for Neurodegenerative Diseases

Tissue-Engineered Models of the Human Brain: State-of-the-Art Analysis and Challenges

Bioengineered 3D Glial Cell Culture Systems and Applications for Neurodegeneration and Neuroinflammation

Vascularizing the brain <i>in vitro</i>

Develop a 3D neurological disease model of human cortical glutamatergic neurons using micropillar-based scaffolds

3D Bioprinted Hyaluronic Acid-Based Cell-Laden Scaffold for Brain Microenvironment Simulation

Beyond animal models: revolutionizing neurodegenerative disease modeling using 3D in vitro organoids, microfluidic chips, and bioprinting

Neuroinflammatory in Vitro Cell Culture Models and the Potential Applications for Neurological Disorders.

Advances in 3D tissue models for neural engineering: self-assembled versus engineered tissue models

Microfluidic Brain-on-a-Chip: Perspectives for Mimicking Neural System Disorders

Engineering Neurovascular Unit and Blood‐Brain Barrier for Ischemic Stroke Modeling

Microfluidic Manipulation for Biomedical Applications in the Central and Peripheral Nervous Systems

Three-Dimensional Organoid System Transplantation Technologies in Future Treatment of Central Nervous System Diseases

In vitro modelling of the neurovascular unit for ischemic stroke research: Emphasis on human cell applications and 3D model design

Human Brain In Vitro Model for Pathogen Infection-Related Neurodegeneration Study

Three-dimensional neuroimmune co-culture system for modeling Parkinson's disease microenvironments in vitro

Human iPSC-Based Modeling of Central Nerve System Disorders for Drug Discovery

Dynamic 3D On-Chip BBB Model Design, Development, and Applications in Neurological Diseases